BioNTech boss confident vaccine will work on UK variant
The chief executive of BioNTech has said the German pharmaceutical company is confident that its coronavirus vaccine works against the UK variant, but further studies are needed to be completely sure.
Ugur Sahin said on Tuesday that “we don’t know at the moment if our vaccine is also able to provide protection against this new variant”, but because the proteins on the variant are 99% the same as the prevailing strains, BioNTech has “scientific confidence” in the vaccine.




